Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,668 | 75,864 | 49,334 | 59,406 | 44,230 |
| Marketable Securities | 237,472 | 206,649 | 154,389 | 196,554 | 228,139 |
| TOTAL | $295,594 | $291,124 | $211,433 | $262,250 | $279,428 |
| Non-Current Assets | |||||
| PPE Net | 2,559 | 2,762 | 3,021 | 2,924 | 3,091 |
| Investments And Advances | 125,908 | 45,216 | 20,039 | 0 | 9,998 |
| Other Non-Current Assets | 7,131 | 7,755 | 8,365 | 8,968 | 9,553 |
| TOTAL | $135,598 | $55,733 | $31,425 | $11,892 | $22,642 |
| Total Assets | $431,192 | $346,857 | $242,858 | $274,142 | $302,070 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,900 | 3,130 | 5,160 | 1,548 | 4,249 |
| TOTAL | $20,179 | $18,050 | $17,617 | $24,846 | $21,248 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,094 | 4,812 | 5,503 | 6,174 | 6,828 |
| TOTAL | $4,094 | $4,812 | $5,503 | $6,174 | $6,828 |
| Total Liabilities | $24,273 | $22,862 | $23,120 | $31,020 | $28,076 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 97,389 | 97,123 | 71,088 | 71,027 | 70,567 |
| Common Shares | 11 | 9 | 7 | 7 | 7 |
| Retained earnings | -661,737 | -629,150 | -592,795 | -562,774 | -526,467 |
| Other shareholders' equity | 615 | 187 | 209 | 379 | 722 |
| TOTAL | $406,919 | $323,995 | $219,738 | $243,122 | $273,994 |
| Total Liabilities And Equity | $431,192 | $346,857 | $242,858 | $274,142 | $302,070 |